SwitchGear Genomics Inc., a leading provider of products for studying the regulatory elements in the human genome, today announced that the company signed an agreement for BioCat GmbH to distribute the innovative LightSwitch Luciferase Assay System™ in Europe. The system consists of a full reporter assay solution including a genome-wide collection of human promoter and 3'UTR luciferase reporters and optimized luciferase assay reagents for measuring transcriptional activation and translational efficiency in living cells.
“The agreement furthers our effort to providing a full and cost-effective reporter assay solution using new channels.”
"We are very excited to partner with BioCat to gain a broader exposure in Europe, a rapidly growing market for us," said Nathan Trinklein, Ph.D., CEO and co-founder of SwitchGear Genomics, "The agreement furthers our effort to providing a full and cost-effective reporter assay solution using new channels."
Under the agreement, BioCat GmbH will promote and sell all components of the LightSwitch Luciferase Assay System in Germany, Austria, and Switzerland with full sales, marketing, and technical support from SwitchGear.
Glyphosate exposure linked to lasting brain inflammation